Apotex recalls Desmopressin Nasal Spray (50 doses) due to defective bottle caps that may dislodge. This could cause the spray to leak or contaminate the product. Consumers should check their bottle's lot number and contact Apotex for details.
“Apotex Desmopressin Nasal Spray Recall: Defective Bottle Caps Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31353-apotex-desmopressin-nasal-spray-recall-defective-bottle-caps-risk. Based on FDA recall #D-0510-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0510-2026%22&limit=1).
The FDA announced on April 8, 2026, that Apotex Corp. is recalling Desmopressin Nasal Spray due to defective bottle caps with dislodged or missing liners. Consumers should stop using the product and contact Apotek for a refund.
The recall involves a defect in a batch of bottle caps where liners may be dislodged or missing. This defect could result in the nasal spray not being delivered properly to the user.
Context
GovInfoNow's records show Apotex Corp. has issued 23 other recalls since June 14, 2007. Recent similar recalls include the Apotex Paxil CR 37.5mg Tablets Recall on August 13, 2026, and the Apotex Brimonidine/Timolol Eye Drops Recall on March 5, 2026. Other recent recalls of similar products include the Lupin Sertraline Tablets Recall (November 5, 2025), the Micro Labs Dorzolamide/Timolol Eye Drops Recall (July 22, 2026), and the Keystone DHP Topical Anesthetic Gel Recall (May 21, 2026).
How to tell if you have this one
Check for the lot number VM4231 on the bottle. The product was manufactured in Toronto, Ontario, Canada, and sold with the NDC code 60505-0815-0.
Brand
Apotex
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Bottle Cap
Inspect the bottle cap for dislodged or missing cap liners. If found, stop using the product immediately.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “U.S.A. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 14 days after the firm started it.
1Firm started the recall
2Published in FDA’s Enforcement Report
3FDA classified it Class II
Dates from the agency record only; steps without a date are left out.
The product may be safe if the bottle cap is intact, but the recall indicates a defect in a specific batch that could cause the cap to dislodge, leading to potential leakage or contamination.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0510-2026 (April 8, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0510-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.